2,093 reports of this reaction
3.1% of all TESTOSTERONE reports
#5 most reported adverse reaction
BLOOD TESTOSTERONE DECREASED is the #5 most commonly reported adverse reaction for TESTOSTERONE, manufactured by ASCEND Therapeutics U.S., LLC. There are 2,093 FDA adverse event reports linking TESTOSTERONE to BLOOD TESTOSTERONE DECREASED. This represents approximately 3.1% of all 67,752 adverse event reports for this drug.
TESTOSTERONE has an overall safety score of 85 out of 100. Patients taking TESTOSTERONE who experience blood testosterone decreased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BLOOD TESTOSTERONE DECREASED is moderately reported among TESTOSTERONE users, representing a notable but not dominant share of adverse events.
In addition to blood testosterone decreased, the following adverse reactions have been reported for TESTOSTERONE:
BLOOD TESTOSTERONE DECREASED has been reported as an adverse event in 2,093 FDA reports for TESTOSTERONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
BLOOD TESTOSTERONE DECREASED accounts for approximately 3.1% of all adverse event reports for TESTOSTERONE, making it a notable side effect.
If you experience blood testosterone decreased while taking TESTOSTERONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.